Data as of Nov 28
| -0.42 / -1.96%|
SurModics, Inc. is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company offers surface modification coating technologies and components for in vitro diagnostic test kits and microarrays. It operates through two segments: The Medical Device unit and The In Vitro Diagnostics unit. The Medical Device unit, which is comprised of surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, and neuro-vascular, and urology, among others. The In Vitro Diagnostics unit, which consists of component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. SurModics was founded in June 1979 and is headquartered in Eden Prairie, MN.
|Gary R. Maharaj||President, Chief Executive Officer & Director|
|Andrew D. C. LaFrence||CFO, VP & Head-Investor Relations|
|Charles W. Olson||Senior Vice President & GM-Medical Device|
|Joseph J. Stich||Vice President & GM-In Vitro Diagnostics|
|Timothy J. Arens||Vice President-Corporate Development & Strategy|